43 /100
MEDIUM RISK
Score updated Apr 13, 2026

CRVS

Corvus Pharmaceuticals, Inc. — Stock Dilution Tracker

Track CRVS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track CRVS — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
20
⚠️ Warrant Exposure
50
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
13%
💰 Capital Raise 18%
• Active ATM program with $200M remaining capacity
📜 Warrant Exercise 15%
• Warrant overhang: 10.6% of shares outstanding
🔔 Track CRVS — Get forecast alerts →
💹 Market Data
Market Cap$1.27B
Shares Outstanding83.99M
Float72.22M
Cash$56.75M
Debt$937.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 15.2% shares (2025Q4 vs prior)
126 institutional holders · 48.72M shares
#1 ORBIMED ADVISORS LLC 7.17M shares
#2 BlackRock, Inc. 5.06M shares
#3 VANGUARD GROUP INC 3.87M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest16.95M
Days to Cover11.1
% of Float23.5%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2025
424B5 ATM Mar 13, 2026
8-K 8K EVENT Mar 13, 2026
4 INSIDER TRANSACTION Jan 30, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track CRVS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CRVS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required